OTHER · Unmapped registry intervention
without intervention type
Find medicine records ·
Find other trials using this name
Clinical trial
The Role of Microbiota on the Development of Lung Cancer
NCT03454685
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedThe Role of Microbiota on the Development of Lung Cancer
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
NSCLC, Stage Iunresolved
NSCLC, Stage IIunresolved
NSCLC, Stage IIIunresolved
NSCLC Stage IVunresolved
Healthy Subjectsunresolved
Interventions
Sponsors & collaborators
Xiaorong Donglead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03454685 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.